Polivy Injection, Powder, Lyophilized, For Solution
Product Images NDC 50242-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polivy (NDC 50242-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Polivy 01)

Diagram illustrating an antibody with potential conjugation sites labeled for attachment of the vcMMAE linker-drug. The chemical structure of the vcMMAE linker-drug is shown, highlighting components mc, vc, PAB, and the MMAE cytotoxic agent, as well as the protease cleavage site. This schematic details the molecular linkage of the drug to the antibody.*

FDA Label Image

Principal Display Panel (140 mg Vial Carton)

Label for POLIVY (polatuzumab vedotin-piiq) Injection, indicating a 140 mg per vial strength. The label specifies it is for intravenous infusion only, single-dose vial, with instructions to reconstitute and dilute prior to administration. It cautions that the product is a cytotoxic agent. The label shows the NDC 50242-105-01 and the manufacturer is Genentech, Inc.*

FDA Label Image

Principal Display Panel (30 mg Vial Carton)

Label of POLIVY (polatuzumab vedotin-piiq) injection, powder, lyophilized for solution, 30 mg per vial. It is indicated for intravenous infusion only and is supplied as a single-dose vial. The label includes a caution that the drug is a cytotoxic agent. Manufactured by Genentech, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.